Healthcare -
Biotechnology - NASDAQ - US
$ 45.07
0.625 %
$ 2.61 B
Market Cap
-38.52
P/E
JANX - STOCK-BASED COMPENSATION
Stock-based Compensation JANX - Janux Therapeutics, Inc.
20 M
LAST VALUE
70.15%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR